Qiagen receives FDA approval for EGFR mutation test

Qiagen Press Release. This is the third CDx test to be approved for EGFR, and it is the second EGFR mutation test for a lung cancer therapeutic released this year (Roche’s COBAS test was released in May as a CDx for erlotinib). Dako’s IHC test was released...

Medicare Punts on Establishing Dx Reimbursement

Medicare Has Stopped Paying Bills For Medical Diagnostic Tests. Patients Will Feel The Effects – Forbes. Centers for Medicare and Medicaid Services (CMS) decided to do away with old code stacking system for test reimbursement, and had a year to come up with a...